Latest article
Xeris Prescription drugs Receives European Fee Approval of Ogluo™ (glucagon) Injection for the Therapy...
CHICAGO & DUBLIN - (BUSINESS WIRE) - Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), ein Spezialpharmaunternehmen, das seine...
Peptron to current 1 month-long diabetes drug at ADA meet
Peptron said Friday the company will unveil its new diabetes treatment, which works continuously for a month, at the American Diabetes Association (ADA) conference...
